Abstract:Cell death is attributed to the unrecoverable disturbance of cells exposed to intracellular or extracellular stimulus. Regulated cell death (RCD), also known as programmed cell death (PCD), involves signaling cascades in which effector molecules participate in and play important roles for maintaining organism homeostasis. As a basic biological phenomenon of cells, RCD displays exceptional influence on the occurrence and development of many pathophysiological processes. N6-methyladenosine (m6A) is an important epigenetic modification that regulates RNA fate and subsequent bioprocesses. It occurs extensively on multiple RNA species and is the most abundant internal modification of eukaryotic messenger RNA (mRNA). The abundance of m6A modification is regulated by its methyltransferases and demethylases, and the diverse biological functions of m6A are executed by distinct m6A binding proteins. Accruing evidence shows that m6A modification participates in eukaryotic cell fate transition and determination. In recent years, the disorder of m6A modification status has been observed during the initiation and progression of various RCDs, including classical apoptosis, necroptosis, pyroptosis, and the newly described ferroptosis. Due to the importance of m6A and RCD in cellular and organismal homeostasis, it is worthwhile to recapitulate and organize the current knowledge of the crosstalk between m6A status and RCDs with distinct biochemical and morphological features, as well as immune consequences. In this chapter, we systematically summarize the regulatory networks of m6A modification on RCDs to provide the profiling of m6A-RCD regulatory axis as comprehensively as possible.

N(6)-methyladenosine Modification: A Vital Role of Programmed Cell Death in Myocardial Ischemia/reperfusion Injury.

Multifaceted Functions of RNA m6A Modification in Modulating Regulated Cell Death

Epitranscriptomic M6a Modification in the Stem Cell Field and Its Effects on Cell Death and Survival.

m6A control programmed cell death in cardiac fibrosis

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

Insights into N6-methyladenosine and programmed cell death in cancer

M6a: an Emerging Role in Programmed Cell Death

RNA M6a Modification: the Mediator Between Cellular Stresses and Biological Effects

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

N6-methyladenosine RNA modification: A promising regulator in central nervous system injury

Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries

Role of N<SUP>6</SUP>-Methyladenosine RNA Modification in Cardiovascular Disease

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases

Role of N6-Methyladenosine RNA Modification in Cardiovascular Disease

RNA m6A Modification in Immunocytes and DNA Repair: The Biological Functions and Prospects in Clinical Application

RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness

Role of m6A RNA Methylation in Ischemic Stroke

Insights into RNA N6-methyladenosine and programmed cell death in atherosclerosis

m6A RNA methylation in brain injury and neurodegenerative disease

N6-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential